CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...